InVivoMAb anti-mouse PD-1 (CD279)
State & local contract award Virginia Awarded
- Contract number
- A207_PO-0483780
- Awardee
- Bio X Cell
- Contracting organization
- University of Virginia
- Cumulative value
- $1,645
About this award
Bio X Cell has been awarded a contract by the University of Virginia on September 23, 2026, for the supply of research-grade immunological products. The contract, identified as A207_PO-0483780, is valued at $1,644.65 and involves the delivery of one unit of InVivoMAb anti-mouse Programmed Death receptor-1 (CD279) monoclonal antibody. This product is being procured for delivery to Ji Song at the University of Virginia in Virginia.
InVivoMAb anti-mouse PD-1 (CD279) is a specialized reagent commonly utilized in immunological research applications, particularly for studies involving immune checkpoint pathways in murine models. The single-unit procurement at $1,644.65 represents a targeted acquisition of this specialized research material by the University of Virginia, reflecting typical transactional patterns for academic research supply contracts. No information regarding contract period of performance duration is provided in the available documentation.
Line items
| Item | Total |
|---|---|
| InVivoMAb anti-mouse PD-1 (CD279) | $1,644.65 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A207_PO-0483780?
Contract A207_PO-0483780 was awarded to Bio X Cell by University of Virginia on September 23, 2026.
How much is contract A207_PO-0483780 worth?
Its cumulative value is $1,645.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award